Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

LEMTRADA vs MAVENCLAD

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. LEMTRADA and MAVENCLAD are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

lemtradamavenclad

Rating

72/100
70/100

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

ALEMTUZUMAB
CLADRIBINE

Manufacturer

Genzyme
Emd Serono

Dosage forms

Injectable
Tablet

Drug class

Cd52-Directed Cytolytic Antibody
Purine Antimetabolite

Boxed warning

Boxed warning
Boxed warning

Treats

B-Cell Chronic Lymphocytic Leukemia
Hairy Cell Leukemia, Non-Hodgkin Lymphoma, Multiple Sclerosis

Frequently asked questions

Which is better-rated, Lemtrada or Mavenclad?

By our independent rating, Lemtrada scores higher — 3.6 vs 3.5 out of 5 for Mavenclad. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Lemtrada and Mavenclad?

Lemtrada contains Alemtuzumab, while Mavenclad contains Cladribine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.